PARP-1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPARP-1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29437-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namepoly(ADP-ribose) polymerase 1
NCBI Gene AliasesADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1, PARS, PPOL, Poly-PARP, pADPRT-1

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapyMolecular therapy. Nucleic acidsSeptember 12, 2023Alves-Vale C, Capela AM, Tavares-Marcos C, Domingues-Silva B, Pereira B, Santos F, Gomes CP, Espadas G, Vitorino R, Sabidó E, et al.

(3) Niraparib-induced STAT3 inhibition increases its antitumor effectsFrontiers in oncologyJanuary 1, 2022Zhao Q, Kohut A, Li YJ, Martincuks A, Austria T, Zhang C, Santiago NL, Borrero RM, Phan XT, Melstrom L, et al.

(4) Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCAJournal of medicinal chemistrySeptember 9, 2021Wang C, Qu L, Li S, Yin F, Ji L, Peng W, Luo H, Lu D, Liu X, Chen X, et al.

(5) PARP Traps Rescue the Pro-Inflammatory Response of Human Macrophages in the In Vitro Model of LPS-Induced TolerancePharmaceuticals (Basel, Switzerland)February 22, 2021Pietrzak J, Gronkowska K, Robaszkiewicz A.Hölzel Diagnostika Handels GmbH (Köln, Germany). Puromycin dihydrochloride, PARP-1 shRNA Plasmid (h) (sc-29437-SH) and Control shRNA Plasmid-A(sc-108060), antibodies: anti-p50 (sc-1190), anti-p65 (sc-372) were from

(9) PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervixOncotargetJuly 2, 2019Mann M, Kumar S, Sharma A, Chauhan SS, Bhatla N, Kumar S, Bakhshi S, Gupta R, Kumar L.

(10) Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor SensitivityCell reportsJune 18, 2019Marcar L, Bardhan K, Gheorghiu L, Dinkelborg P, Pfäffle H, Liu Q, Wang M, Piotrowska Z, Sequist LV, Borgmann K, et al.

(11) NR4A Nuclear Receptors Target Poly-ADP-Ribosylated DNA-PKcs Protein to Promote DNA RepairCell reportsFebruary 19, 2019Munnur D, Somers J, Skalka G, Weston R, Jukes-Jones R, Bhogadia M, Dominguez C, Cain K, Ahel I, Malewicz M.

(12) Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling PathwayMediators of inflammationJanuary 1, 2019Zhang JN, Ma Y, Wei XY, Liu KY, Wang H, Han H, Cui Y, Zhang MX, Qin WD.

(13) Nuclear cGAS suppresses DNA repair and promotes tumorigenesisNatureNovember 1, 2018Liu H, Zhang H, Wu X, Ma D, Wu J, Wang L, Jiang Y, Fei Y, Zhu C, Tan R, et al.

(14) Trastuzumab-Resistant HER2⁺ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) InhibitionMolecular cancer therapeuticsMay 1, 2018Wielgos ME, Zhang Z, Rajbhandari R, Cooper TS, Zeng L, Forero A, Esteva FJ, Osborne CK, Schiff R, LoBuglio AF, et al.

(15) PARP1 facilitates EP300 recruitment to the promoters of the subset of RBL2-dependent genesBiochimica et biophysica acta. Gene regulatory mechanismsDecember 4, 2017Robaszkiewicz A, Wiśnik E, Regdon Z, Chmielewska K, Virág L.

(18) Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinomaOncology lettersAugust 1, 2017Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, et al.

(19) PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathwayFree radical biology & medicineJuly 1, 2017Hocsak E, Szabo V, Kalman N, Antus C, Cseh A, Sumegi K, Eros K, Hegedus Z, Gallyas F Jr, Sumegi B, et al.

(20) Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathyBiochimica et biophysica acta. Molecular basis of diseaseJuly 1, 2017Mishra M, Kowluru RA.

PARP-1 shRNA Plasmid (h)